Charles J Homcy
CIK 1192591 · View on SEC EDGAR ↗
First SEC filing: June 10, 2026 · Latest: June 10, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 11, 2025 | BBIO | S 10b5-1 | 50,000 | $48.00 | $2,400,000 | 916,674 Direct | -5.17% | Disposed | 72.2% (price as of 2026-08-21) |
| Aug. 8, 2025 | BBIO | S 10b5-1 | 58,338 | $46.64 | $2,720,884 | 966,674 Direct | -5.69% | Disposed | 77.2% (price as of 2026-08-21) |
| Aug. 8, 2025 | BBIO | S 10b5-1 | 191,662 | $45.87 | $8,791,536 | 1,025,012 Direct | -15.75% | Disposed | 80.2% (price as of 2026-08-21) |
| Oct. 16, 2020 | BBIO | S 10b5-1 | 10,256 | $41.00 | $420,496 | 1,203,767 Direct | -0.84% | Disposed | 101.6% (price as of 2026-08-21) |
| Sept. 30, 2020 | BBIO | S 10b5-1 | 10,000 | $38.00 | $380,000 | 1,203,767 Direct | -0.82% | Disposed | 117.5% (price as of 2026-08-21) |
| Sept. 29, 2020 | BBIO | S 10b5-1 | 18,200 | $37.50 | $682,500 | 1,203,767 Direct | -1.49% | Disposed | 120.4% (price as of 2026-08-21) |
| Sept. 25, 2020 | BBIO | S 10b5-1 | 15,396 | $37.47 | $576,888 | 1,221,967 Direct | -1.24% | Disposed | 120.6% (price as of 2026-08-21) |
| Sept. 25, 2020 | BBIO | S 10b5-1 | 65,661 | $36.68 | $2,408,445 | 1,237,363 Direct | -5.04% | Disposed | 125.3% (price as of 2026-08-21) |
| Feb. 10, 2020 | BBIO | S 10b5-1 | 20,000 | $36.00 | $720,000 | 1,342,291 Direct | -1.47% | Disposed | 129.6% (price as of 2026-08-21) |
| Jan. 14, 2020 | BBIO | S 10b5-1 | 10,000 | $35.00 | $350,000 | 1,362,291 Direct | -0.73% | Disposed | 136.1% (price as of 2026-08-21) |
Showing latest 100 of 116 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 22, 2026 | BBIO | Stock Option (Right to Buy) | Common Stock (5,277) | $68.92 | June 21, 2036 | 5,277 | Acquired |
| June 8, 2026 | MAZE | Stock Option (Right to Buy) | Common Stock (18,000) | $23.58 | June 7, 2036 | 18,000 | Acquired |
| Sept. 22, 2025 | MAZE | Stock Option (Right to Buy) | Common Stock (18,000) | $23.67 | Sept. 21, 2035 | 18,000 | Acquired |
| June 20, 2025 | BBIO | Stock Option (Right to Buy) | Common Stock (8,425) | $41.73 | June 19, 2035 | 8,425 | Acquired |
| Feb. 3, 2025 | MAZE | Series B Preferred Stock | Common Stock (8,807) | — | — | 72,727 | Disposed |
| Feb. 3, 2025 | MAZE | Series C Preferred Stock | Common Stock (20,717) | — | — | 169,405 | Disposed |
| Feb. 3, 2025 | MAZE | Series D-1 Preferred Stock | Common Stock (7,422) | — | — | 71,564 | Disposed |
| Dec. 9, 2024 | MAZE | Stock Option (Right to Buy) | Common Stock (80,385) | $10.42 | March 3, 2031 | 80,385 | Acquired |
| Dec. 9, 2024 | MAZE | Stock Option (Right to Buy) | Common Stock (80,385) | $11.19 | March 3, 2031 | 80,385 | Disposed |
| Dec. 9, 2024 | MAZE | Stock Option (Right to Buy) | Common Stock (5,704) | $10.42 | March 8, 2033 | 5,704 | Acquired |
| Dec. 9, 2024 | MAZE | Stock Option (Right to Buy) | Common Stock (5,704) | $17.74 | March 8, 2033 | 5,704 | Disposed |
| Dec. 9, 2024 | MAZE | Stock Option (Right to Buy) | Common Stock (46,675) | $10.42 | April 22, 2034 | 46,675 | Acquired |
| Dec. 9, 2024 | MAZE | Stock Option (Right to Buy) | Common Stock (46,675) | $14.08 | April 22, 2034 | 46,675 | Disposed |
| Dec. 9, 2024 | MAZE | Stock Option (Right to Buy) | Common Stock (45,638) | $10.42 | Dec. 8, 2034 | 45,638 | Acquired |
| Nov. 26, 2024 | MAZE | Series D-1 Preferred Stock | Common Stock (7,422) | — | — | 71,564 | Acquired |
| Nov. 26, 2024 | MAZE | 8% Convertible Note due 2026 | Series D-1 Preferred Stock (71,564) | — | Dec. 15, 2026 | — | Disposed |
| June 21, 2024 | BBIO | Stock Option (Right to Buy) | Common Stock (26,014) | $27.36 | June 20, 2034 | 26,014 | Acquired |
| Feb. 16, 2024 | BBIO | Restricted Stock Units | Common Stock (3,760) | — | — | 3,760 | Disposed |
| Nov. 16, 2023 | BBIO | Restricted Stock Units | Common Stock (3,760) | — | — | 3,760 | Disposed |
| Aug. 16, 2023 | BBIO | Restricted Stock Units | Common Stock (3,760) | — | — | 3,760 | Disposed |
| June 21, 2023 | BBIO | Stock Option (right to buy) | Common Stock (51,501) | $16.75 | June 21, 2033 | 51,501 | Acquired |
| May 16, 2023 | BBIO | Restricted Stock Units | Common Stock (3,759) | — | — | 3,759 | Disposed |
| Feb. 16, 2023 | BBIO | Restricted Stock Units | Common Stock (3,760) | — | — | 3,760 | Disposed |
| Nov. 16, 2022 | BBIO | Restricted Stock Units | Common Stock (3,760) | — | — | 3,760 | Disposed |
| Aug. 16, 2022 | BBIO | Restricted Stock Units | Common Stock (3,760) | — | — | 3,760 | Disposed |
| June 22, 2022 | BBIO | Stock Option (right to buy) | Common Stock (104,921) | $8.45 | June 22, 2032 | 104,921 | Acquired |
| May 16, 2022 | BBIO | Restricted Stock Units | Common Stock (3,759) | — | — | 3,759 | Disposed |
| Feb. 28, 2022 | BBIO | Restricted Stock Units | Common Stock (30,078) | — | — | 30,078 | Acquired |
| Dec. 2, 2021 | BBIO | Stock Option (right to buy) | Common Stock (55,011) | $40.03 | Dec. 1, 2031 | 55,011 | Acquired |
| June 29, 2021 | PLRX | Stock Option (right to buy) | Common Stock (13,286) | $28.20 | June 28, 2031 | 13,286 | Acquired |
| June 17, 2021 | BBIO | Stock Option (right to buy) | Common Stock (38,895) | $62.63 | June 16, 2031 | 38,895 | Acquired |
| Oct. 16, 2020 | BBIO | Stock Option (Right to Buy) | Common Stock (10,256) | $17.00 | June 26, 2029 | 10,256 | Disposed |
| Sept. 30, 2020 | BBIO | Stock Option (Right to Buy) | Common Stock (10,000) | $17.00 | June 26, 2029 | 10,000 | Disposed |
| June 2, 2020 | BBIO | Stock Option (right to buy) | Common Stock (112,422) | $29.00 | June 1, 2030 | 112,422 | Acquired |
| Jan. 14, 2020 | BBIO | Stock Option (Right to Buy) | Common Stock (10,000) | $17.00 | June 26, 2029 | 10,000 | Disposed |
| Dec. 12, 2019 | BBIO | Stock Option (right to buy) | Common Stock (82,878) | $37.45 | Dec. 11, 2029 | 82,878 | Acquired |
| July 1, 2019 | BBIO | Management Incentive Units | Common Stock (290,476) | — | — | 290,476 | Disposed |
| July 1, 2019 | BBIO | Management Incentive Units | Common Stock (418,016) | — | — | 418,016 | Disposed |
| July 1, 2019 | BBIO | Management Incentive Units | Common Stock (406,723) | — | — | 406,723 | Disposed |
| July 1, 2019 | BBIO | Series B Units | Common Stock (66,729) | — | — | 66,729 | Disposed |
| July 1, 2019 | BBIO | Common Units | Common Stock (132,317) | — | — | 132,317 | Disposed |
| July 1, 2019 | BBIO | Common Units | Common Stock (47,165) | — | — | 47,165 | Disposed |
| May 11, 2011 | GERN | Stock Option (right to buy) | Common Stock (10,000) | $4.91 | May 11, 2014 | 10,000 | Acquired |
| May 19, 2010 | GERN | Stock Option (right to buy) | Common Stock (10,000) | $5.29 | May 19, 2020 | 10,000 | Acquired |
| May 29, 2009 | GERN | Stock Option (right to buy) | Common Stock (10,000) | $6.52 | May 29, 2019 | 10,000 | Acquired |
| May 28, 2008 | GERN | Stock Option (right to buy) | Common Stock (10,000) | $3.97 | May 28, 2018 | 10,000 | Acquired |
| May 22, 2008 | CYTK | Non-Qualified Stock Option (right to buy) | Common Stock (15,000) | $3.83 | May 22, 2018 | 15,000 | Acquired |
| May 24, 2007 | CYTK | Non-Qualified Stock Option (right to buy) | Common Stock (10,000) | $6.55 | May 24, 2017 | 10,000 | Acquired |
| May 24, 2007 | CYTK | Non-Qualified Stock Option (right to buy) | Common Stock (7,500) | $6.55 | May 24, 2017 | 7,500 | Acquired |
| May 23, 2007 | GERN | Stock Option (right to buy) | Common Stock (10,000) | $9.32 | May 23, 2017 | 10,000 | Acquired |
| May 25, 2006 | CYTK | Non-Qualified Stock Option (right to buy) | Common Stock (7,500) | $7.29 | May 25, 2016 | 7,500 | Acquired |
| May 24, 2006 | GERN | Stock Option (right to buy) | Common Stock (20,000) | $6.63 | May 24, 2016 | 20,000 | Acquired |
| May 19, 2005 | CYTK | Non-Qualified Stock Option (right to buy) | Common Stock (7,500) | $5.55 | May 19, 2015 | 7,500 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 23 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 30, 2025 | MAZE | Common Stock | 28,523 | Direct |
| Jan. 30, 2025 | MAZE | Series B Preferred Stock→ Common Stock (72,727) | 72,727 | Direct |
| Jan. 30, 2025 | MAZE | Series C Preferred Stock→ Common Stock (169,405) | 169,405 | Direct |
| Jan. 30, 2025 | MAZE | Series D-1 Preferred Stock→ Common Stock (71,564) | 71,564 | Indirect |
| Jan. 30, 2025 | MAZE | Stock Option (Right to Buy)→ Common Stock (80,385) | 80,385 | Direct |
| Jan. 30, 2025 | MAZE | Stock Option (Right to Buy)→ Common Stock (5,704) | 5,704 | Direct |
| Jan. 30, 2025 | MAZE | Stock Option (Right to Buy)→ Common Stock (46,675) | 46,675 | Direct |
| Jan. 30, 2025 | MAZE | Stock Option (Right to Buy)→ Common Stock (45,638) | 45,638 | Direct |
| June 2, 2020 | PLRX | Common Stock | 73,378 | Direct |
| June 2, 2020 | PLRX | Stock Option (right to buy)→ Common Stock (23,601) | 23,601 | Direct |
| June 2, 2020 | PLRX | Stock Option (right to buy)→ Common Stock (28,155) | 28,155 | Direct |
| June 27, 2019 | BBIO | Common Units→ Common Stock | — | Direct |
| June 27, 2019 | BBIO | Common Units→ Common Stock | — | Direct |
| June 27, 2019 | BBIO | Series B Units→ Common Stock | — | Direct |
| June 27, 2019 | BBIO | Management Incentive Units→ Common Stock | — | Direct |
| June 27, 2019 | BBIO | Management Incentive Units→ Common Stock | — | Direct |
| June 27, 2019 | BBIO | Management Incentive Units→ Common Stock | — | Direct |
| June 27, 2019 | BBIO | Stock Option (right to buy)→ Common Stock (290,463) | 290,463 | Direct |
| July 19, 2005 | GERN | Stock Option (right to buy)→ Common Stock (45,000) | 45,000 | Direct |
| July 27, 2004 | CYTK | Employee Stock Option (right to buy)→ Common Stock (30,000) | 30,000 | Direct |
| July 27, 2004 | CYTK | Employee Stock Option (right to buy)→ Common Stock (12,500) | 12,500 | Direct |
| April 28, 2004 | CYTK | Employee Stock Option (right to buy)→ Common Stock | — | Direct |
| April 28, 2004 | CYTK | Employee Stock Option (right to buy)→ Common Stock | — | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $500,000 | $100,000 | — | — | — | — | $55,812 | $1,855,805 |
| 2019 | $513,808 | — | $2,111,579 | $3,128,716 | — | — | $221,737 | $5,975,842 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.